Poly(A) polymerase phosphorylation is dependent on novel interactions with cyclins

Molecular and Cellular Biology

Volumn 20, Issue 14, 2000, Pages 5310-5320

  Bond, Gareth L ^a   Prives, Carol ^a   Manley, James L ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; RNA POLYMERASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY;

AMINO ACID MOTIFS; ANIMALS; CDC2 PROTEIN KINASE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; CYCLINS; G1 PHASE; G2 PHASE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; POLYNUCLEOTIDE ADENYLYLTRANSFERASE;

EID: 0033934693     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.14.5310-5320.2000     Document Type: Article

References (65)

1. Adams, P. D., X. Li, W. R. Sellers, K. B. Baker, X. Leng, J. W. Harper, Y. Taya, and W. G. Kaelin, Jr. 1999. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol. Cell. Biol. 19:1068-1080.
2. Adams, P. D., W. R. Sellers, S. K. Sharma, A. D. Wu, C. M. Nalin, and W. G. Kaelin, Jr. 1996. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16:6623-6633.
3. Ballantyne, S., A. Bilger, J. Astrom, A. Virtanen, and M. Wakens. 1995. Poly(A) polymerases in the nucleus and cytoplasm of frog oocytes: dynamic changes during oocyte maturation and early development. RNA 1:64-78.
4. Barabino, S. M., and W. Keller. 1999. Last but not least: regulated poly(A) tail formation. Cell 99:9-11.
5. Benz, E. W., Jr., M. J. Getz, D. J. Wells, and H. L. Moses. 1977. Nuclear RNA polymerase activities and poly(A)-containing mRNA accumulation in cultured AKR mouse embryo cells stimulated to proliferate. Exp. Cell Res. 108:157-165.
6. Chen, I. T., M. Akamatsu, M. L. Smith, F. D. Lung, O. Duba, P. P. Roller, A. J. Furnace, Jr., and P. M. O'Connor. 1996. Characterization of p21Cip1/ Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction. Oncogene 12:595-607.
7. Coleman, M. S., J. J. Hutton, and F. J. Bollum. 1974. Terminal riboadenylate transferase in human lymphocytes. Nature 248:407-409.
8. Colgan, D. F., and J. L. Manley. 1997. Mechanism and regulation of mRNA polyadenylation. Genes Dev. 11:2755-2766.
9. Colgan, D. F., K. G. Murthy, C. Prives, and J. L. Manley. 1996. Cell-cycle related regulation of poly(A) polymerase by phosphorylation. Nature 384: 282-285.
10. Colgan, D. F., K. G. Murthy, W. Zhao, C. Prives, and J. L. Manley. 1998. Inhibition of poly(A) polymerase requires p34cdc2/cyclin B phosphorylation of multiple consensus and non-consensus sites. EMBO J. 17:1053-1062.
11. Cooke, C., and J. C. Alwine. 1996. The cap and the 3′ splice site similarly affect polyadenylation efficiency. Mol. Cell. Biol. 16:2579-2584.
12. Dantonel, J. C., K. G. Murthy, J. L. Manley, and L. Tora. 1997. Transcription factor TFIID recruits factor CPSF for formation of 3′ end of mRNA. Nature 389:399-402.
13. Desai, D., H. C. Wessling, R. P. Fisher, and D. O. Morgan. 1995. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Mol. Cell. Biol. 15:345-350.
14. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev. 8:1772-1786.
15. Dynlacht, B. D., K. Moberg, J, A. Lees, E. Harlow, and L. Zhu. 1997. Specific regulation of E2F family members by cyclin-dependent kinases. Mol. Cell. Biol. 17:3867-3875.
16. Fan, H., and S. Penman. 1970. Regulation of protein synthesis in mammalian cells. II. Inhibition of protein synthesis at the level of initiation during mitosis. J. Mol. Biol. 50:655-670.
17. Fisher, R. P., P. Jin, H. M. Chamberlin, and D. O. Morgan. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83:47-57.
18. 2/M transition of Xenopus oocytes. Oncogene 15:2541-51.
19. Foulkes, N. S., F. Schlotter, P. Pevet, and P. Sassone-Corsi. 1993. Pituitary hormone FSH directs the CREM functional switch during spermatogenesis. Nature 362:264-267.
20. Getz, M. J., P. K. Elder, E. W. Benz, Jr., R. E. Stephens, and H. L. Moses. 1976. Effect of cell proliferation on levels and diversity of poly(A)-containing mRNA. Cell 7:255-265.
21. Gottesfeld, J. M., and D. J. Forbes. 1997. Mitotic repression of the transcriptional machinery. Trends Biochem. Sci. 22:197-202.
22. Gunderson, S. I., K. Beyer, G. Martin, W. Keller, W. C. Boelens, and L. W. Mattaj. 1994. The human U1A snRNP protein regulates polyadenylation via a direct interaction with poly(A) polymerase. Cell 76:531-541.
23. Gunderson, S. I., M. Polycarpou-Schwarz, and I. W. Mattaj. 1998. U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol. Cell 1:255-264.
24. Gunderson, S. I., S. Vagner, M. Polycarpou-Schwarz, and I. W. Mattaj. 1997. Involvement of the carboxyl terminus of vertebrate poly(A) polymerase in U1A autoregulation and in the coupling of splicing and polyadenylation. Genes Dev. 11:761-773.
25. Harper, J. W., and S. J. Elledge. 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56-64.
26. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, et al. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
27. Harper, J. W., S. J. Elledge, K, Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
28. Hauser, H., R. Knippers, and K. P. Schafer. 1978. Increased rate of RNA-polyadenylation. An early response in concanavalin A activated lymphocytes. Exp. Cell Res. 111:175-184.
29. Hirose, Y., and J. L. Manley. 1998. RNA polymerase II is an essential mRNA polyadenylation factor. Nature 395:93-96.
30. + RNA in mammalian mitochondria. Cell 3:335-339.
31. Horton, L. E., and D. J. Templeton. 1997. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity. Oncogene 14:491-498.
32. Hunter, T., and J. Pines. 1994. Cyclins and cancer. II. cyclin D and CDK inhibitors come of age. Cell 79:573-582.
33. Jeffrey, P. D., A. A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N. P. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature 376:313-320.
34. Keller, W., and L. Minvielle-Sebastia. 1997. A comparison of mammalian and yeast pre-mRNA 3′-end processing. Curr. Opin. Cell Biol. 9:329-336.
35. Kelly, B. L., K. G. Wolfe, and J. M. Roberts. 1998. Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein. Proc. Natl. Acad. Sci. USA 95:2535-2540.
36. King, R. W., P. K. Jackson, and M. W. Kirschner. 1994. Mitosis in transition. Cell 79:563-571.
37. Kohtz, J. D., S. F. Jamison, C. L. Will, P. Zuo, R. Luhrmann, M. A. Garcia-Blanco, and J. L. Manley. 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368:119-124.
38. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, Jr., and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
39. LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862.
40. Lees, E. M., and E. Harlow. 1993. Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase. Mol. Cell. Biol. 13:1194-1201.
41. Lewis, J. D., S. I. Gunderson, and I. W. Mattaj. 1995. The influence of 5′ and 3′ end structures on pre-mRNA metabolism. J. Cell Sci. Suppl. 19:13-19.
42. Lin, J., C. Reichner, X. Wu, and A. J. Levine. 1996. Analysis of wild-type and mutant p21WAF-1 gene activities. Mol. Cell. Biol. 16:1786-1793.
43. Ma, T., N. Zou, B. Y. Lin, L. T. Chow, and J. W. Harper. 1999. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc. Natl. Acad. Sci. USA 96:382-387.
44. McCracken, S., N. Kong, K. Yankulov, S. Ballantyne, G. Pan, J. Greenblatt, S. D. Patterson, M. Wickens, and D. L. Bentley. 1997. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385:357-361.
45. Morris, M. C., and G. Divita. 1999. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes. J. Mol. Biol. 286:475-487.
46. Nigg, E. A. 1995. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471-480.
47. Pan, Z. Q., A. Amin, and J. Hurwitz. 1993. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities. J. Biol. Chem. 268:20443-20451.
48. Peeper, D. S., L. L. Parker, M. E. Ewen, M. Toebes, F. L. Hall, M. Xu, A. Zantema, A. J. van der Eb, and H. Piwnica-Worms. 1993. A-and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J. 12:1947-1954.
49. Petersen, B. O., J. Lukas, S. r. CS, J. Bartek, and K. Helin. 1999. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J. 18:396-410.
50. Pines, J. 1997. Cyclin-dependent kinase inhibitors: the age of crystals. Biochim. Biophys. Acta 1332:M39-M42.
51. Russo, A. A., P. D. Jeffrey, A. K. Patten, J. Massague, and N. P. Pavletich. 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325-331.
52. Sachs, A. B., P. Sarnow, and M. W. Hentze. 1997. Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell 89:831-838.
53. Saha, P., Q. Eichbaum, E. D. Silberman, B. J. Mayer, and A. Dutta. 1997. p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases. Mol. Cell. Biol. 17:4338-4345.
54. Schulman, B. A., D. L. Lindstrom, and E. Harlow. 1998. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc. Natl. Acad. Sci. USA 95:10453-10458.
55. Steward, D. L., J, R. Shaeffer, and R. M. Humphrey. 1968. Breakdown and assembly of polyribosomes in synchronized Chinese hamster cells. Science 161:791-793.
56. Takagaki, Y., R. L. Seipelt, M. L. Peterson, and J. L. Manley. 1996. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 87:941-952.
57. Tassan, J. P., M. Jaquenoud, A. M. Fry, S. Frutiger, G. J. Hughes, and E. A. Nigg. 1995. In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J. 14:5608-5617.
58. Wahle, E., and U. Kuhn. 1997. The mechanism of 3′ cleavage and polyadenylation of eukaryotic pre-mRNA. Prog. Nucleic Acid Res. Mol. Biol. 57:41-71.
59. Wickens, M., P. Anderson, and R. J. Jackson. 1997. Life and death in the cytoplasm: messages from the 3′ end. Curr. Opin. Genet. Dev. 7:220-232.
60. Xiong, Y., G. J. Hannon, H. Zhang, D. Cassa, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
61. Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758.
62. Zhao, J., L. Hyman, and C. Moore. 1999. Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol. Mol. Biol. Rev. 63:405-445.
63. Zhao, W., and J. L. Manley. 1996. Complex alternative RNA processing generates an unexpected diversity of poly(A) polymerase isoforms. Mol. Cell. Biol. 16:2378-2386.
64. Zhao, W., and J. L. Manley. 1998. Deregulation of poly(A) polymerase interferes with cell growth. Mol. Cell. Biol. 18:5010-5020.
65. Zhu, L., E. Harlow, and B. D. Dynlacht. 1995. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 9:1740-1752.